Growth Hormone Stack

Why CJC-1295 + Ipamorelin Is the Gold Standard

This is the most widely used growth hormone peptide combination in the world. Anti-aging clinics prescribe it. Biohackers run it. Athletes (pre-WADA ban) relied on it. The reason is simple pharmacology: two peptides, two different receptor pathways, one synergistic result.

CJC-1295 (no DAC / Mod GRF 1-29) is a GHRH analog. It binds to GHRH receptors on the anterior pituitary and tells somatotroph cells to produce and release growth hormone. Think of it as the “volume knob” — it determines how much GH the pituitary is prepared to release.

Ipamorelin is a GHRP (Growth Hormone Releasing Peptide). It binds to ghrelin receptors on the same pituitary cells and triggers the actual release event. Think of it as the “trigger” — it fires the loaded GH pulse.

The Synergy

When you activate both pathways simultaneously:

• CJC-1295 primes the pituitary with a GHRH signal: “make GH and get ready to release it”
• Ipamorelin fires the ghrelin signal: “release it now”

The result is a GH pulse 3–5x larger than either peptide produces alone. This isn’t additive — it’s genuinely synergistic. The combined receptor activation produces a disproportionately larger response.

This synergy has been demonstrated in clinical pharmacology research. GHRH and GHRP pathways converge on cAMP and calcium signaling in somatotroph cells. Dual activation amplifies intracellular signaling beyond what either pathway achieves independently.

Why Ipamorelin (Not GHRP-2, GHRP-6, or Hexarelin)

The GHRP slot in the stack could theoretically be filled by any growth hormone releasing peptide. Ipamorelin is preferred because:

• No cortisol spike — GHRP-2 and Hexarelin elevate cortisol. Cortisol is catabolic and counterproductive for body composition goals.
• No prolactin spike — GHRP-2 and Hexarelin elevate prolactin. Elevated prolactin suppresses testosterone and can cause gynecomastia in men.
• Manageable appetite — GHRP-6 causes intense, sometimes uncontrollable hunger spikes. Ipamorelin’s appetite increase is mild.
• No desensitization — Hexarelin shows reduced response within 2 weeks of continuous use. Ipamorelin maintains efficacy across 8–12 week cycles.

The tradeoff is slightly less raw GH output compared to GHRP-2 or Hexarelin. For the vast majority of users, the cleaner side effect profile is worth it.

Standard Stack Protocol

Optimal Schedule (3x Daily)

Time	CJC-1295 (no DAC)	Ipamorelin	Notes
Morning (fasted)	100 mcg	100 mcg	Immediately upon waking, before food
Post-workout	100 mcg	100 mcg	Fasted or 2+ hours post-meal
Pre-sleep	100 mcg	100 mcg	30 min before bed, 2+ hours after dinner

Total daily exposure: 300 mcg CJC-1295 + 300 mcg Ipamorelin

Practical Schedule (2x Daily)

Time	CJC-1295 (no DAC)	Ipamorelin	Notes
Morning (fasted)	100 mcg	100 mcg	Upon waking, before food
Pre-sleep	100 mcg	100 mcg	30 min before bed, fasted

Total daily exposure: 200 mcg CJC-1295 + 200 mcg Ipamorelin

Minimum Effective Schedule (1x Daily)

Time	CJC-1295 (no DAC)	Ipamorelin	Notes
Pre-sleep	100 mcg	100 mcg	30 min before bed, fasted

The pre-sleep dose is the single highest-value injection because it amplifies the natural nocturnal GH surge. If you can only commit to one injection per day, this is the one.

Cycle Structure

Phase	Duration	Protocol
Active cycle	8–12 weeks	CJC-1295 + Ipamorelin, 2–3x daily
Off period	4 weeks minimum	No GH peptides (MK-677 optional as bridge)
Repeat	As desired	Most users run 3–4 cycles per year

Fasting Protocol (Critical)

This is the single most important variable in GH peptide effectiveness. Insulin is a potent suppressor of GH release at the pituitary level. Elevated blood sugar → elevated insulin → blunted GH pulse. Injecting in a fed state wastes the peptide.

Rules:

1. Fast for 2+ hours before each injection
2. Wait 30–60 minutes after injection before eating
3. Carbohydrates are the biggest offender — they spike insulin fastest
4. Protein has moderate insulin impact — still avoid in the fasting window
5. Fat has minimal insulin impact but follow the full fast for consistency

Practical implementation:

• Morning dose: inject immediately upon waking (natural overnight fast)
• Post-workout dose: train fasted or wait 2+ hours after pre-workout meal
• Pre-sleep dose: stop eating 2+ hours before bed, inject 30 minutes before sleep

Reconstitution and Administration

Preparing Your Peptides

CJC-1295 (no DAC) — 2 mg vial:

• Add 2 mL bacteriostatic water → 1,000 mcg/mL
• 100 mcg dose = 10 units on insulin syringe
• One vial = 20 doses (7–10 days at 2–3x daily)

Ipamorelin — 5 mg vial:

• Add 2.5 mL bacteriostatic water → 2,000 mcg/mL
• 100 mcg dose = 5 units on insulin syringe
• One vial = 50 doses (~17–25 days at 2–3x daily)

Combining in One Syringe

You can draw both peptides into a single insulin syringe:

1. Wipe both vial stoppers with alcohol pads
2. Draw CJC-1295 first (10 units)
3. Without changing the needle, insert into the Ipamorelin vial and draw (5 more units)
4. Total in syringe: 15 units containing 100 mcg CJC + 100 mcg Ipamorelin
5. Inject subcutaneously (abdomen, thigh, or upper arm)

Never pre-mix vials. Draw and inject immediately. Different peptides in the same vial can degrade each other over time.

Storage

• Reconstituted vials: refrigerate at 2–8°C, use within 28 days
• Unreconstituted powder: refrigerate, or freeze for long-term storage
• Protect from light and heat

Results Timeline

Individual results vary. This timeline reflects commonly reported outcomes across the biohacking, anti-aging, and athletic communities.

Weeks 1–2: Sleep and Recovery

• Deeper, more restorative sleep — the most commonly reported early effect. Onset within 2–5 days for many users.
• Vivid dreams (increased REM sleep)
• Mild water retention (face, hands — temporary)
• Faster recovery between training sessions

Weeks 3–5: Skin and Healing

• Improved skin texture, hydration, and elasticity
• Faster healing of minor wounds and injuries
• Hair and nail growth acceleration
• Subtle improvements in body composition beginning

Weeks 6–8: Body Composition

• Noticeable fat loss, particularly abdominal
• Improved muscle tone and fullness
• Increased training capacity and work output
• Joint comfort improving

Weeks 8–12: Full Expression

• Measurable changes in body composition (track with calipers or DEXA)
• Strength gains from improved recovery and protein synthesis
• Sustained energy levels throughout the day
• Cumulative anti-aging benefits becoming visible

What Bloodwork Should Show

At 4–6 weeks, retest IGF-1:

• Expect a 30–60% increase from baseline
• If IGF-1 hasn’t moved, verify: fasting protocol, peptide source quality, reconstitution math, storage conditions
• Also monitor: fasting glucose (should be stable), HbA1c (especially if adding MK-677)

Advanced Protocols

Adding MK-677 as a Bridge

During the 4-week off period between cycles (or on rest days during a cycle):

Protocol	CJC + Ipamorelin	MK-677
Training days	100 mcg + 100 mcg, 2–3x daily	Off
Rest days	Off	10 mg before bed
Off-cycle period	Off	10 mg before bed (4 weeks)

This maintains baseline GH support 7 days a week through different mechanisms, preventing the complete GH drop during off periods.

Stacking with Healing Peptides

The GH stack pairs naturally with recovery peptides:

• BPC-157 (protocol) — GH potentiates BPC-157’s healing effects. BPC-157 upregulates GH receptors in tendon fibroblasts (up to 7-fold).
• TB-500 (protocol) — systemic healing support alongside GH-driven recovery

Stacking with Fat Loss

For body recomposition, some users combine:

• GH stack (CJC + Ipamorelin) for elevated GH/IGF-1
• Fasted morning cardio immediately after the morning GH injection — GH mobilizes fatty acids for oxidation
• Time carbohydrate intake to post-workout windows to minimize insulin interference with GH signaling

Safety

Common Side Effects

• Water retention — mild, temporary. Most noticeable in the first 2–3 weeks (face, hands). Indicates the stack is working.
• Numbness/tingling — carpal tunnel-like symptoms from elevated GH. Dose-dependent. Reduce dose if persistent.
• Injection-site reactions — minor redness, itching, soreness. Rotate sites.
• Headaches — occasional, usually mild.
• Increased hunger — mild with Ipamorelin (would be much worse with GHRP-6).
• Vivid dreams / deeper sleep — almost universal. Generally considered a benefit.

Serious Considerations

Insulin sensitivity. The GH stack alone has minimal insulin impact. Adding MK-677 or running very long cycles (16+ weeks) increases the risk. Monitor fasting glucose and HbA1c.

Not FDA-approved. Neither CJC-1295 nor Ipamorelin is approved for human use. The FDA classified GH secretagogues as Category 2 in 2023.

Banned by WADA. Both peptides are prohibited under S2 (GH Secretagogues). Tested athletes face suspension.

Cancer precaution. GH and IGF-1 promote cell growth. Do not use with active malignancies, tumor history, or significant cancer risk factors.

Source quality. Both peptides must come from reputable sources with third-party CoA, HPLC purity testing, and mass spectrometry confirmation.

Contraindications

• Active cancer or tumor history
• Pituitary disorders or acromegaly
• Diabetes (GH affects insulin sensitivity)
• Congestive heart failure
• Pregnant or breastfeeding
• Under 18
• WADA/USADA tested athletes

What Comes Next

• Read individual protocols for CJC-1295 and Ipamorelin for deeper mechanism and dosing detail
• Consider MK-677 for rest days or bridge periods — MK-677 Protocol
• Compare all GH options in the Growth Hormone Peptides Compared guide
• Add healing peptides — BPC-157 or the Wolverine Stack
• Use the Reconstitution Calculator for exact unit counts